ICD-10 Coding for Fibrocystic Disease of the Breast(N60.19, N60.19B, N60.19O)
Learn about the ICD-10 coding for fibrocystic disease of the breast, including documentation requirements and common pitfalls.
Complete code families applicable to Fibrocystic Disease of the Breast
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| N60.3 | Fibrosclerosis of breast | Use when biopsy confirms stromal fibrosis or sclerosis. |
|
| N60.19 | Other benign mammary dysplasia | Use when there are multiple cysts without fibrosis. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutFibrocystic Disease of the Breast
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Fibrocystic Disease of the Breast.
Failing to document imaging results
Impact
Clinical: May lead to misdiagnosis or inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential denial of claims due to insufficient documentation.
Mitigation
Ensure all imaging findings are included in the patient record.
Using N60.9 (Unspecified) without medical necessity
Impact
Reimbursement: May result in lower reimbursement rates., Compliance: Non-compliance with specificity requirements., Data Quality: Decreases accuracy of medical records.
Mitigation
Query provider for specific fibrocystic changes with or without fibrosis.
Unspecified coding
Impact
Using unspecified codes can trigger audits.
Mitigation
Ensure all documentation is specific and complete.